Status:

UNKNOWN

Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

Lead Sponsor:

Xuanwu Hospital, Beijing

Conditions:

Acute Ischemic Stroke

Eligibility:

All Genders

18-80 years

Brief Summary

This is a prospective cohort study to investigate the early impact of evolocumab on patients with acute ischemic stroke (AIS) in China. Evolocumab, a proprotein convertase subtilisin/kexin taye 9 inhi...

Detailed Description

Patients aged 18-80 years old admitted to the Department of Neurology, Xuanwu Hospital, Capital Medical University, with a definite diagnosis of acute ischemic stroke and receiving lipid-lowering ther...

Eligibility Criteria

Inclusion

  • Diagnosed with acute ischemic stroke;
  • Aged 18-80 years, gender unlimited;
  • The fasting LDL-C≥1.8mmol/L (70mg/dL);
  • Received lipid-lowering therapy with statins with or without evolocumab;
  • Premorbid mRS ≤ 2;
  • NIHSS ≤ 15;
  • Subjects participated in the study voluntarily and signed informed consent.

Exclusion

  • Participants who changed their lipid-lowering regimen;
  • Participants allergic to PCSK9 inhibitors;
  • Participants treated with cholesterol ester transfer protein inhibitor within 12 months prior to enrollment;
  • LDL or plasma apheresis within 12 months prior to enrollment;
  • Last known left ventricular ejection fraction \< 30%
  • Known hemorrhagic stroke at any time;
  • Severe renal dysfunction, defined as an estimated glomerular filtration rate (eGFR) \< 20 mL/min/1.73m2 at final screening;
  • Active liver disease or hepatic dysfunction, defined as aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \> 3 times;
  • Pregnant or lactating women;
  • Severe, concomitant non-cardiovascular disease that is expected to reduce life expectancy to less than 3 years.

Key Trial Info

Start Date :

December 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06134635

Start Date

December 1 2023

End Date

December 1 2024

Last Update

November 18 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.